- Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
- CareDx Reports First Quarter 2024 Results
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CareDx to Report First Quarter 2024 Financial Results
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
- CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
- CareDx Appoints Bryan Riggsbee to Its Board of Directors
- CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
- CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
More ▼
Key statistics
On Friday, CareDx Inc (CDNA:NMQ) closed at 15.50, -4.02% below its 52-week high of 16.15, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.30 |
---|---|
High | 15.58 |
Low | 14.85 |
Bid | 15.02 |
Offer | 15.50 |
Previous close | 14.78 |
Average volume | 1.16m |
---|---|
Shares outstanding | 52.08m |
Free float | 49.57m |
P/E (TTM) | -- |
Market cap | 807.30m USD |
EPS (TTM) | -3.43 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼